225 related articles for article (PubMed ID: 34348617)
1. Nanotherapeutics and Nanotheragnostics for Cancers: Properties, Pharmacokinetics, Biopharmaceutics, and Biosafety.
Morsink M; Parente L; Silva F; Abrantes A; Ramos A; Primo I; Willemen N; Sanchez-Lopez E; Severino P; Souto EB
Curr Pharm Des; 2022; 28(2):104-115. PubMed ID: 34348617
[TBL] [Abstract][Full Text] [Related]
2. Improved Targeting of Cancers with Nanotherapeutics.
Foster C; Watson A; Kaplinsky J; Kamaly N
Methods Mol Biol; 2017; 1530():13-37. PubMed ID: 28150194
[TBL] [Abstract][Full Text] [Related]
3. Development of nanoparticulate systems with action in breast and ovarian cancer: nanotheragnostics.
de Sousa Cunha F; Dos Santos Pereira LN; de Costa E Silva TP; de Sousa Luz RA; Nogueira Mendes A
J Drug Target; 2019 Aug; 27(7):732-741. PubMed ID: 30207742
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticles for cancer therapy: a review of influencing factors and evaluation methods for biosafety.
Li J; Wu T; Li S; Chen X; Deng Z; Huang Y
Clin Transl Oncol; 2023 Jul; 25(7):2043-2055. PubMed ID: 36807057
[TBL] [Abstract][Full Text] [Related]
5. Promising effects of nanomedicine in cancer drug delivery.
Wakaskar RR
J Drug Target; 2018 Apr; 26(4):319-324. PubMed ID: 28875739
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicine formulations for the delivery of antiviral drugs: a promising solution for the treatment of viral infections.
Lembo D; Donalisio M; Civra A; Argenziano M; Cavalli R
Expert Opin Drug Deliv; 2018 Jan; 15(1):93-114. PubMed ID: 28749739
[TBL] [Abstract][Full Text] [Related]
7. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
8. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles.
Liu Y; Miyoshi H; Nakamura M
Int J Cancer; 2007 Jun; 120(12):2527-37. PubMed ID: 17390371
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle Drug Delivery Can Reduce the Hepatotoxicity of Therapeutic Cargo.
Yang F; Medik Y; Li L; Tian X; Fu D; Brouwer KLR; Wagner K; Sun B; Sendi H; Mi Y; Wang AZ
Small; 2020 Feb; 16(7):e1906360. PubMed ID: 31972070
[TBL] [Abstract][Full Text] [Related]
10. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
[TBL] [Abstract][Full Text] [Related]
11. Potential applications and human biosafety of nanomaterials used in nanomedicine.
Su H; Wang Y; Gu Y; Bowman L; Zhao J; Ding M
J Appl Toxicol; 2018 Jan; 38(1):3-24. PubMed ID: 28589558
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in targeted nanomedicine as promising antitumor therapeutics.
Hejmady S; Pradhan R; Alexander A; Agrawal M; Singhvi G; Gorain B; Tiwari S; Kesharwani P; Dubey SK
Drug Discov Today; 2020 Dec; 25(12):2227-2244. PubMed ID: 33011342
[TBL] [Abstract][Full Text] [Related]
13. Drug targeting systems for cancer therapy: nanotechnological approach.
Tigli Aydin RS
Mini Rev Med Chem; 2015; 14(13):1048-54. PubMed ID: 25138089
[TBL] [Abstract][Full Text] [Related]
14. Modulating the tumor microenvironment with new therapeutic nanoparticles: A promising paradigm for tumor treatment.
Zhang Y; Ho SH; Li B; Nie G; Li S
Med Res Rev; 2020 May; 40(3):1084-1102. PubMed ID: 31709590
[TBL] [Abstract][Full Text] [Related]
15. Bioengineering CXCR4-overexpressing cell membrane functionalized ROS-responsive nanotherapeutics for targeting cerebral ischemia-reperfusion injury.
Luo L; Zang G; Liu B; Qin X; Zhang Y; Chen Y; Zhang H; Wu W; Wang G
Theranostics; 2021; 11(16):8043-8056. PubMed ID: 34335979
[No Abstract] [Full Text] [Related]
16. Advancements in Polymer and Lipid-based Nanotherapeutics for Cancer Drug Targeting.
Jahangir MA; Taleuzzaman M; Kala C; Gilani SJ
Curr Pharm Des; 2020; 26(40):5119-5127. PubMed ID: 32867646
[TBL] [Abstract][Full Text] [Related]
17. Nanotherapeutics for the Treatment of Cancer and Arthritis.
Patel P; Meghani N; Kansara K; Kumar A
Curr Drug Metab; 2019; 20(6):430-445. PubMed ID: 30479211
[TBL] [Abstract][Full Text] [Related]
18. Nanomedicine: An effective tool in cancer therapy.
Aftab S; Shah A; Nadhman A; Kurbanoglu S; Aysıl Ozkan S; Dionysiou DD; Shukla SS; Aminabhavi TM
Int J Pharm; 2018 Apr; 540(1-2):132-149. PubMed ID: 29427746
[TBL] [Abstract][Full Text] [Related]
19. Hydrogel Microtumor Arrays to Evaluate Nanotherapeutics.
Liu Y; Nemec S; Kopecky C; Stenzel MH; Kilian KA
Adv Healthc Mater; 2023 Jun; 12(14):e2201696. PubMed ID: 36373218
[TBL] [Abstract][Full Text] [Related]
20. Calibration-quality cancer nanotherapeutics.
Perry JL; Kai MP; Reuter KG; Bowerman C; Christopher Luft J; DeSimone JM
Cancer Treat Res; 2015; 166():275-91. PubMed ID: 25895873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
